Fact CheckerSign in

NCT06055283Not yet recruiting

Effects of Intradialytic Aerobic Exercise in Chronic Kidney Patients

Effects of Intradialytic Aerobic Exercise on Peripheral Muscle Function, Functional Status and Motivation in Chronic Kidney Patients: A Randomized Controlled Clinical Trial

Source: ClinicalTrials.gov · Last updated 26 Sept 2023 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The goal of this clinical trial is to evaluate the effects of intradialytic aerobic exercise on muscle capacity, functionality and motivation of patients with chronic kidney disease undergoing hemodialysis. The main question it aims to answer are: • Is intradialytic aerobic exercise at moderate intensity effective in improving peripheral muscle function, functional status and motivation in patients with chronic kidney disease?

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
90 (estimated)
First submitted
5 Jun 2023
Start date
Nov 2023
Primary completion date
14 Jun 2026
Lead sponsor
University of the State of Santa Catarina
NCT number
NCT06055283

What you commit to

  • Study type: Interventional
  • Planned participants: 90
  • From Nov 2023 to the primary completion date, 14 Jun 2026
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • who have participated in other exercise protocols in the last 6 months prior to the present study

Other illness

  • severe heart failure according to the New York Heart Association classification

Other

  • patients who do not reach a score equal to or above 20 assessed by the Mini Mental State Examination
  • musculoskeletal alteration that prevents the correct execution of the assessment activities
  • patients who show signs of clinical instability during the hemodialysis procedure or after training for two consecutive sessions will be excluded throughout the protocol.

Who the study is looking for

  • diagnosis of chronic kidney disease undergoing renal replacement therapy via hemodialysis
  • aged 20 to 65 years
  • low body mass index at overweight (21 kg/m2 to 29.9 kg/m2)
  • regular renal replacement therapy via hemodialysis for 6 months, without acute complications related to the diagnosis and/or comorbidities for the period of 3 months prior to the evaluation and intervention.

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.